Article Detail - JE Part A
COVID-19: New Administration Code 0074A for Pfizer Pediatric Vaccine Booster Dose
On May 17, 2022, the FDA amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (PDF) to authorize the use of a single booster pediatric dose (orange cap) for all patients 5-11 years old. CMS issued a new code, effective May 17, 2022, for the vaccine administration:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation
- Short descriptor: ADM SARSCV2 10MCG TRS-SUCR B
For more information, visit the COVID-19 Provider Toolkit, and get the most current list of billing codes, payment allowances, and effective dates. (Note: you may need to refresh your browser if you recently visited these webpages).
Source: CMS MLN Connects dated May 26, 2022
Last Updated Thu, 26 May 2022 14:32:08 +0000